Use of rhPTH(1-84) for hypoparathyroidism during early pregnancy and lactation
We present the first report of use of recombinant human parathyr oid hormone (1-84) (rhPTH(1-84)) in a hypoparathyroid patient during early pregnancy and lactation. The patient developed postoperative hypoparathyroidism as a 28-year-old woman following total thyroidectomy for multinodular goiter. Sh...
Main Authors: | E Pauline Liao, Natalie E Cusano |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2023-06-01
|
Series: | Endocrinology, Diabetes & Metabolism Case Reports |
Online Access: | https://edm.bioscientifica.com/view/journals/edm/2023/2/EDM22-0401.xml |
Similar Items
-
Continuous rhPTH (1–34) treatment in chronic hypoparathyroidism
by: Carmina Teresa Fuss, et al.
Published: (2020-06-01) -
Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.
by: Ebeling, P, et al.
Published: (2003) -
Transitory Activation and Improved Transition from Erosion to Formation within Intracortical Bone Remodeling in Hypoparathyroid Patients Treated with rhPTH(1–84)
by: Pernille vanDijk Christiansen, et al.
Published: (2023-12-01) -
Screening of differentially expressed transcription factors in keratinocytes with overexpression of EGFR induced by rhPTH(1-34)
by: Wenqi ZHAO, et al.
Published: (2023-08-01) -
Graphene Oxide/RhPTH(1-34)/Polylactide Composite Nanofibrous Scaffold for Bone Tissue Engineering
by: Fan Fei, et al.
Published: (2023-03-01)